Epigenetic modification, including acetylation, of cellular proteins is involved in the pathogenesis of RA (40); this operates by modulating the activity of signaling pathways or the transcription of key factors, such as T-bet, Gata3, RORγt, and Foxp3, which influence the fate of effector T cells. The gene discussed is FOXP3; the disease is rheumatoid arthritis.